Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 661

1.

A Nested Case-Control Study of Metabolically Defined Body Size Phenotypes and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC).

Murphy N, Cross AJ, Abubakar M, Jenab M, Aleksandrova K, Boutron-Ruault MC, Dossus L, Racine A, Kühn T, Katzke VA, Tjønneland A, Petersen KE, Overvad K, Quirós JR, Jakszyn P, Molina-Montes E, Dorronsoro M, Huerta JM, Barricarte A, Khaw KT, Wareham N, Travis RC, Trichopoulou A, Lagiou P, Trichopoulos D, Masala G, Krogh V, Tumino R, Vineis P, Panico S, Bueno-de-Mesquita HB, Siersema PD, Peeters PH, Ohlsson B, Ericson U, Palmqvist R, Nyström H, Weiderpass E, Skeie G, Freisling H, Kong SY, Tsilidis K, Muller DC, Riboli E, Gunter MJ.

PLoS Med. 2016 Apr 5;13(4):e1001988. doi: 10.1371/journal.pmed.1001988. eCollection 2016 Apr.

2.

The association between metabolic health, obesity phenotype and the risk of breast cancer.

Park YM, White AJ, Nichols HB, O'Brien KM, Weinberg CR, Sandler DP.

Int J Cancer. 2017 Jun 15;140(12):2657-2666. doi: 10.1002/ijc.30684. Epub 2017 Mar 28.

3.

Metabolically healthy obesity and the risk for subclinical atherosclerosis.

Kim TJ, Shin HY, Chang Y, Kang M, Jee J, Choi YH, Ahn HS, Ahn SH, Son HJ, Ryu S.

Atherosclerosis. 2017 Jul;262:191-197. doi: 10.1016/j.atherosclerosis.2017.03.035. Epub 2017 Mar 28.

PMID:
28385392
4.

Cardiovascular risk in different obesity phenotypes over a decade follow-up: Tehran Lipid and Glucose Study.

Mirzaei B, Abdi H, Serahati S, Barzin M, Niroomand M, Azizi F, Hosseinpanah F.

Atherosclerosis. 2017 Mar;258:65-71. doi: 10.1016/j.atherosclerosis.2017.02.002. Epub 2017 Feb 3.

PMID:
28213199
5.

Metabolically healthy obesity and risk of incident CKD.

Hashimoto Y, Tanaka M, Okada H, Senmaru T, Hamaguchi M, Asano M, Yamazaki M, Oda Y, Hasegawa G, Toda H, Nakamura N, Fukui M.

Clin J Am Soc Nephrol. 2015 Apr 7;10(4):578-83. doi: 10.2215/CJN.08980914. Epub 2015 Jan 29.

6.

Metabolically healthy obesity also has risk for hyperuricemia among Chinese general population: A cross-sectional study.

Chen Y, Zhang N, Sun G, Guo X, Yu S, Yang H, Zheng L, Sun Y.

Obes Res Clin Pract. 2016 Sep;10 Suppl 1:S84-S95. doi: 10.1016/j.orcp.2016.03.008. Epub 2016 Apr 6.

PMID:
27061989
7.

Metabolic Phenotype and Risk of Colorectal Cancer in Normal-Weight Postmenopausal Women.

Liang X, Margolis KL, Hendryx M, Rohan TE, Groessl EJ, Thomson CA, Kroenke CH, Simon MS, Lane D, Stefanick M, Luo J.

Cancer Epidemiol Biomarkers Prev. 2017 Feb;26(2):155-161. doi: 10.1158/1055-9965.EPI-16-0761.

8.

Metabolically-healthy obesity is associated with higher prevalence of colorectal adenoma.

Sinn DH, Min YW, Son HJ, Rhee PL, Paik SW, Hong SN, Gwak GY.

PLoS One. 2017 Jun 21;12(6):e0179480. doi: 10.1371/journal.pone.0179480. eCollection 2017.

9.

Predictors of incident obesity phenotype in nonobese healthy adults.

Eftekharzadeh A, Asghari G, Serahati S, Hosseinpanah F, Azizi A, Barzin M, Mirmiran P, Azizi F.

Eur J Clin Invest. 2017 May;47(5):357-365. doi: 10.1111/eci.12743. Epub 2017 Apr 5.

PMID:
28294315
10.

Relations of Metabolically Healthy and Unhealthy Obesity to Digital Vascular Function in Three Community-Based Cohorts: A Meta-Analysis.

Brant LC, Wang N, Ojeda FM, LaValley M, Barreto SM, Benjamin EJ, Mitchell GF, Vasan RS, Palmisano JN, Münzel T, Blankenberg S, Wild PS, Zeller T, Ribeiro AL, Schnabel RB, Hamburg NM.

J Am Heart Assoc. 2017 Mar 8;6(3). pii: e004199. doi: 10.1161/JAHA.116.004199. Review.

11.

Metabolically healthy obesity and health-related quality of life: A prospective cohort study.

Lopez-Garcia E, Guallar-Castillón P, Garcia-Esquinas E, Rodríguez-Artalejo F.

Clin Nutr. 2017 Jun;36(3):853-860. doi: 10.1016/j.clnu.2016.04.028. Epub 2016 May 6.

PMID:
27184975
12.

Hypertension outcomes in metabolically unhealthy normal-weight and metabolically healthy obese children and adolescents.

Ding WQ, Yan YK, Zhang MX, Cheng H, Zhao XY, Hou DQ, Mi J.

J Hum Hypertens. 2015 Sep;29(9):548-54. doi: 10.1038/jhh.2014.124. Epub 2015 Feb 5.

PMID:
25652533
13.

Metabolic subtypes and risk of mortality in normal weight, overweight, and obese individuals with CKD.

Hanks LJ, Tanner RM, Muntner P, Kramer H, McClellan WM, Warnock DG, Judd SE, Gutiérrez OM; REGARDS Investigators.

Clin J Am Soc Nephrol. 2013 Dec;8(12):2064-71. doi: 10.2215/CJN.00140113. Epub 2013 Oct 31.

14.

Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis.

Kramer CK, Zinman B, Retnakaran R.

Ann Intern Med. 2013 Dec 3;159(11):758-69. doi: 10.7326/0003-4819-159-11-201312030-00008. Review.

PMID:
24297192
15.

Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status.

Campbell PT, Jacobs ET, Ulrich CM, Figueiredo JC, Poynter JN, McLaughlin JR, Haile RW, Jacobs EJ, Newcomb PA, Potter JD, Le Marchand L, Green RC, Parfrey P, Younghusband HB, Cotterchio M, Gallinger S, Jenkins MA, Hopper JL, Baron JA, Thibodeau SN, Lindor NM, Limburg PJ, Martínez ME; Colon Cancer Family Registry.

J Natl Cancer Inst. 2010 Mar 17;102(6):391-400. doi: 10.1093/jnci/djq011. Epub 2010 Mar 5.

16.

The Distribution of Obesity Phenotypes in HIV-Infected African Population.

Nguyen KA, Peer N, de Villiers A, Mukasa B, Matsha TE, Mills EJ, Kengne AP.

Nutrients. 2016 Jun 2;8(6). pii: E299. doi: 10.3390/nu8060299.

17.

Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis.

Ma J, Li H, Giovannucci E, Mucci L, Qiu W, Nguyen PL, Gaziano JM, Pollak M, Stampfer MJ.

Lancet Oncol. 2008 Nov;9(11):1039-47. doi: 10.1016/S1470-2045(08)70235-3. Epub 2008 Oct 3.

18.

Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study.

Eckel N, Li Y, Kuxhaus O, Stefan N, Hu FB, Schulze MB.

Lancet Diabetes Endocrinol. 2018 Sep;6(9):714-724. doi: 10.1016/S2213-8587(18)30137-2. Epub 2018 May 31.

PMID:
29859908
19.

Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk.

Du T, Yu X, Yuan G, Zhang J, Sun X.

Cardiovasc Diabetol. 2015 Oct 29;14:144. doi: 10.1186/s12933-015-0306-0.

20.

The risk of chronic kidney disease in a metabolically healthy obese population.

Jung CH, Lee MJ, Kang YM, Hwang JY, Kim EH, Park JY, Kim HK, Lee WJ.

Kidney Int. 2015 Oct;88(4):843-50. doi: 10.1038/ki.2015.183. Epub 2015 Jun 24.

PMID:
26108064

Supplemental Content

Support Center